Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #36 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Jubilant Pharmova Limited (this stock) | 15,635 | 677.0 | 5.6% | -10.5% | 0.51% | 62 | 37 | 36 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| June 30, 2026 | 2,229 | 86 | 56 | ₹ |
| March 31, 2026 | 2,290 | 176 | 119 | ₹ |
| Dec. 31, 2025 | 2,122 | 94 | 56 | ₹ |
| Sept. 30, 2025 | 1,966 | 190 | 120 | ₹ |
| June 30, 2025 | 1,901 | 154 | 102 | ₹ |
| March 31, 2025 | 1,929 | 206 | 151 | ₹ |
| Dec. 31, 2024 | 1,822 | 131 | 101 | ₹ |
| Sept. 30, 2024 | 1,752 | 144 | 102 | ₹ |
| June 30, 2024 | 1,732 | 500 | 482 | ₹ |
| Dec. 31, 2023 | 1,677 | 88 | 66 | ₹ |
| Sept. 30, 2023 | 1,680 | 89 | 62 | ₹ |
| June 30, 2023 | 1,587 | 27 | 6 | ₹ |
| March 31, 2023 | 1,678 | -103 | -101 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
| Year ended | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) |
|---|---|---|---|
| March 31, 2026 | 8,280 | 614 | 398 |
| March 31, 2025 | 7,234 | 981 | 836 |
| March 31, 2023 | 6,282 | 16 | -65 |
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | 1,227 | -1,260 | 95 | 1,449 | -222 |
| March 31, 2025 | 1,072 | 488 | -1,453 | 1,116 | -44 |
| March 31, 2023 | 661 | -544 | -157 | 814 | -154 |
| March 31, 2022 | 838 | -380 | -33 | 600 | 238 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 15,523 | 7,096 | 7,077 | 248 | 2,972 | 4,109 | 2,539 | 1,267 | 3,510 | 1,232 |
| March 31, 2025 | 12,756 | 6,239 | 6,239 | 287 | 2,150 | 3,510 | 2,165 | 1,088 | 2,132 | 1,129 |
| March 31, 2023 | — | — | — | — | — | — | — | — | — | — |
| March 31, 2022 | — | — | — | — | — | — | — | — | — | — |
